Related Experiment Video
Updated: Jun 20, 2026
07:35
Aggravation of Myocardial Ischemia upon Particulate Matter Exposure in Atherosclerosis Animal Model
Published on: December 10, 2021
Long-term exposure to traffic-related particulate matter impairs cognitive function in the elderly
Ulrich Ranft1, Tamara Schikowski, Dorothee Sugiri
1Institut für Umweltmedizinische Forschung (IUF) an der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany. ranft@uni-duesseldorf.de
Environmental Research
|September 8, 2009
Summary
Long-term exposure to traffic-related fine particulate matter (PM) may contribute to Alzheimer's disease (AD) development. This study found associations between PM exposure and mild cognitive impairment (MCI) in older women.
Area of Science:
- Environmental Health
- Neuroscience
- Epidemiology
Background:
- Fine particulate matter (PM) can reach the brain, causing inflammation linked to neurodegenerative diseases.
- Alzheimer's disease (AD) pathogenesis may involve brain inflammation.
- Mild cognitive impairment (MCI) is a precursor to AD.
Purpose of the Study:
- To investigate the association between long-term fine PM exposure and MCI.
- To explore the potential role of PM in Alzheimer's disease development.
Main Methods:
- Assessed long-term exposure to PM10 and traffic-related PM in 399 women (aged 68-79).
- Evaluated MCI using neuropsychological tests and odor identification.
- Utilized regression analysis adjusted for confounders.
Main Results:
- Found consistent effects of traffic-related air pollution on cognitive test performance.
- Observed a dose-response relationship between PM exposure and cognitive decline.
- Indicated a potential link between chronic PM exposure and AD pathogenesis.
Conclusions:
- Chronic exposure to traffic-related fine PM may be implicated in Alzheimer's disease development.
- Air pollution is a potential environmental risk factor for cognitive impairment and AD.
Related Concept Videos
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...